NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — Vesalius Longevity Labs, the first soon-to-be publicly traded company dedicated exclusively to longevity science, today announced a landmark partnership with Wisp, the largest women’s telehealth provider in the United States. Together, the companies will co-develop a new line of peptide therapeutics designed specifically for women, marking a pivotal expansion of Vesalius’ growing Peptual™ portfolio and a major step toward addressing the gender gap in longevity care.
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — Vesalius Longevity Labs, the first soon-to-be publicly traded company dedicated exclusively to longevity science, today announced a landmark partnership with Wisp, the largest women’s telehealth provider in the United States. Together, the companies will co-develop a new line of peptide therapeutics designed specifically for women, marking a pivotal expansion of Vesalius’ growing Peptual™ portfolio and a major step toward addressing the gender gap in longevity care.
